GABA receptor

From Proteopedia

Jump to: navigation, search

Glycosylated human GABAB receptor subunit 1(grey) and subunit 2 (green) (PDB code 4mqe)

References


Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004). Molecular structure and physiological functions of GABAB receptors. Physiological reviews, 84(3), 835-867.

Citrome, L., Javitt, D., Kantrowitz, J. (2009). GABAB Receptors, Schizophrenia and Sleep Dysfunction. CNS Drugs, 23(8), 681-691.

Cryan, J.F., Kaupman, K. (2005). Don’t worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression. Trends in Pharmacological Sciences, 26(1), 36-43.

Filip, M., Frankowska, M., et al., (2015). GABAB receptors as a therapuetic strategy in substance use disorders: Focus on positive allosteric modulators. Neuropharmacology. (38), 36-47.

Geng, Y., Bush, M., Mosyak, L., Wang, F., & Fan, Q. R. (2013). Structural mechanism of ligand activation in human GABAB receptor. Nature, 504(7479), 254-259.

Gumerov, V., Hegyi, H. (2015). MicroRNA-derived network analysis of differentially methylated genes in schizophrenia, implicating GABA receptor B1 [GABBR1] and protein kinase B [AKT1].Gumerov and Heygl Biology Direct. 10:59, 1-15.

Kerr, D. I. B., and J. Ong. "Clinical Potential of GABA B Receptor Modulators." CNS Drug Reviews. 11.3 (2005): 317-334.

Kerr, D. I. B., and J. Ong. "Gaba B receptors." Pharmacology & therapeutics. 67.2 (1995): 187-246.

Proteopedia Page Contributors and Editors (what is this?)

Jonathan Hurst, Gregory Holley, Michal Harel, Alexander Berchansky, Patrick Farrell, Joel L. Sussman, Karli Ribsam, Jaime Prilusky

Personal tools